1. Arora S. Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors/ S. Arora, R. Velichinskii, R.W. Lesh, U. Ali, M. Kubiak, P. Bansal, H. Borghaei, M.J. Edelman, Y. Boumber// Advances in Therapy.-2019.-   V.36, Is.10.-P 2638.  doi: 10.1007/s12325-019-01051-z.(IF 3.260)
  2. Abramov S. N. Analysis of autophagy and LC3-associated phagocytosis in T-lymphocytes of patients with severe asthma/S. N. Abramov, Y. V. Skibo, A. Z. Abramova, M. V. Tihomirova //Human Gene Therapy.-2019.-V. 30, No. 11.-A120-A121.- P352 (IF 3.855)
  3. Beck T. N. Circulating tumor cell and cell-free RNA capture and expression analysis identify platelet-associated genes in metastatic lung cancer / T.N. Beck,  Y.A. Boumber, Aggarwal, J Pei, C. Thrash-Bingham, P. Fittipaldi, R. Vlasenkova, C. Rao, H Borghaei, M. Cristofanilli, R. Mehra, I. Serebriiskii , R. K. Alpaugh .// BMC Cancer – 2019.-V.19,N.1.-603. doi: 10.1186/s12885-019-5795-x. .(IF 2.933)
  4. Beck T.N. An improved method of delivering a sclerosing agent for the treatment of malignant pleural effusion / T.N. Beck, A.Y. Deneka, L. Chai, C. Kanach, P. Johal, N.J. Alvarez, Y. Boumber, E.A. Golemis, G.W. Laub // Cancer. – 2019.-V.9, N.1.-A: 614. doi: 10.1186/s12885-019-5777-z. (IF 6.102)
  5. Beck T.N. Case report: reinitiating pembrolizumab treatment after small bowel perforation/ Beck TN, Kudinov AE, Dulaimi E5, Boumber Y. // BMC Cancer.-2019 .-V.19, N1.-А.379- З1-9 doi: 10.1186/s12885-019-5577-5.(IF 2.933)
  6. Bodor J.N. Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC) / J.N. Bodor, Y. Boumber, H. Borghaei // Cancer. – 2019.-N11.-  https: //doi.org/10.1002/cncr.32468 (IF 6.102)
  7. Deneka A.Y. Tumor-Targeted Drug Conjugates as an Emerging Novel Therapeutic Approach in Small Cell Lung Cancer (SCLC)/ A.Y. Deneka, Y. Boumber, T. Beck, E.A. Golemis // Cancers.-2019. -V.11, Is.9. doi: 10.3390/cancers11091297. (IF 5.326)
  8. Farias F.H.G. A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts/ FHG Farias, J Dahlqvist, SV Kozyrev, D Leonard, M Wilbe, SN Abramov, A Alexsson, GR Pielberg, H Hansson-Hamlin, A G ndersson , K Tandre, AA Bengtsson, C Sjöwall, E Svenungsson, I Gunnarsson, S Rantapää-Dahlqvist, AC Syvänen , JK Sandling , ML Eloranta, L Rönnblom, K Lindblad-Toh // Eur J Hum Genet. - 2019 .- V.27, N.3. –  P.432 - 441. doi: 10.1038/s41431-018-0297-x.( IF: 3.650)
  9. Kiseleva, А. A. Unexpected activities in regulating ciliation contribute to off target effects of targeted drugs / А.A. Kiseleva, V.A. Korobeynikov, A.S. Nikonova, P. Zhang, P. Makhov, M.B. Einarson, H. Liu, I.G. Serebriiskii, J. Peterson, E.A. Golemis // Clinical Cancer Research. – 2019.-V. 25, N13.- P.4179-4193 https://doi.org/10.1158/1078-0432.ccr-18-3535 (IF 10.199)
  10. Korobeynikov V. Combined inhibition of aurora A and p21-activated kinase 1 as a new treatment strategy in breast cancer/V. Korobeynikov, M. Borakove, Y. Feng, W. M. Wuest, A. B. K, A. S. Nikonova, I. Serebriiskii, J. Chernoff, V. F. Borges, Erica A. Golemis, E.Shagisultanova // Breast Cancer Res Treat.- 2019.-V.177, N.2.-P. 369–382.  doi: 10.1007/s10549-019-05329-2 (IF 3.471)
  11. Lieu C.H. Comprehensive Genomic Landscapes in Early and Later Onset Colorectal Cancer / C.H. Lieu , E.A. Golemis , I.G. Serebriiskii, J. Newberg, A. Hemmerich, C. Connelly, W.A. Messersmith, C Eng, S.G. Eckhardt, G. Frampton, M. Cooke, J.E. Meyer // Clinical Cancer Research.-2019.- V .25, N.19.-:clincanres.0899/ DOI: 10.1158/1078-0432.CCR-19-0899) (IF 10.199)
  12. Nicolas E. Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma/ E. Nicolas, E.V. Demidova, W.Iqbal, I.G. SerebriiskiiR.Vlasenkova, P. Ghatalia, Y.Zhou, K. Rainey, A.F. Forman, R.L. Dunbrack, Jr., E.A. Golemis, M.J. Hall, M.B. Daly, S. Arora// Molecular Genetics and Genomic Medicine.-2019.-V.7. N.3.-  e556doi: 10.1002/mgg3.556 (IF 2.448)
  13. Serebriiskii I. Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients / I. Serebriiskii, C. Connelly, G. Frampton, J. Newberg, M. Cooke, V. Miller, S. Ali, J. S. Ross, E. Handorf, S. Arora, Ch. Lieu, E. A. Golemis, J. E. Meyer// Nature Communications.- 2019.-V.10, N1.-Р. Article 3722 doi: 10.1038/s41467-019-11530-0.(IF 11.880)
  14. Zhang, P. Microscopy-based automated live cell screening for small molecules that affect ciliation / P. Zhang, A. Kiseleva, V. Korobeynikov, H. Liu, M. Einarson, E. Golemis // Frontiers in Genetics. – 2019. – V. 10. – A.75. – P. 1-15, DOI:10.3389/fgene.2019.00075. eCollection 2019.(IF 4.097)
  15. Zolotoverkchova Z. I. Detection of Macro-thyrotropin in patients with Hashimotos Thyroiditis and subclinical hypothyroidism /Z. I. Zolotoverkchova, E. M. Biktagirova, G. P. Semakov, S.N. Abramov, T. A. Nevzorova, G. R. Vagapova, Z. I. Abramova //Human Gene Therapy.-2019.-V.30.- No. 11.-A120-120 (IF 3.855)
  16. Skibo Yu. V. Analysis of the expression of key proteins-regulators of apoptosis and autophagy in T-lymphocytes of patients with bronchial asthma / Yu. V. Skibo, M.V. Tikhomirova, S.N. Abramov, E. M. Biktagirova, I. D. Reshetnikova, Z. I. Abramova //Uchenye Zapiski Kazanskogo Universiteta. Seriya Estestvennye Nauki. - 2019.- V. 161, N. 4, P. 551-567 (In Russian) ( WoS, Scopus)
  17. Biktagirova E.M. Determination of the phenomenon of macrotyrotropinemia in patients with autoimmune thyroiditis and subclinical hypothyroidism / E. M. Biktagirova, G. P. Semakov, N. I. Zolotoverkhova, T. A. Nevzorova, I. A. Andrianova, N. G. Evtyugina, N. I. Akberova, A.N. Khisamutdinov, G.R. Vagapova, Z. I. Abramova //Medical Immunology (Russia).-2019.- V. 21, N. 6.- P. 814-824. (Scopus SJR 0,120)


1. Nikonova A. Ganetespib limits ciliation and cystogenesis inautosomal dominant polycystic kidney disease (ADPKD) / Anna S. Nikonova, Alexander Y. Deneka, A. Kiseleva, Vladislav Korobeynikov, Anna Gaponova, Ilya G. Serebriiskii, Meghan C. Kopp, Harvey H. Hensley, Brian L. Egleston Tamina N. Seeger-Nukpezah, Stephen Somlo, David A. Proia, and Erica A. Golemis/ FASEB. 2018 Jan 16. DOI: 10.1096/fj.201700909R
2. Liu H. Ciliary signaling and therapeutic response in cancer / Hanqing Liu, Anna Kiseleva,  Erica Golemis // Nature Reviews Cancer. 2018. – V. 18, pp. 511–524 
3. Gabbasov R. NEDD9 promotes oncogenic signaling, a stem/mesenchymal gene signature, and aggressive ovarian cancer growth in mice / Rashid Gabbasov, Fang, Xiao, Caitlin Howe, Laura E. Bickel, Shane W. O'Brien, Daniel Benrubi3, Thuy-Vy Do1, Yan Zhou, Emmanuelle Nicolas, Samuel Litwin, Sachiko Seo, Erica A. Golemis and Denise C. Connolly / Oncogene. - 2018
4. Mazitova A. Cisplatin treatment induces autophagy anddown-regulates E-cadherin in ovariancarcinoma cells in vitro: a preliminary study /A. Mazitova,Y. Topchu, E. Biktagirova, E. Maykova,R. Gabbasov, Z. Abramova //FEBS Open Bio.-2018.-V.8.-S1.-P.342-343
5. Tikhomirova M. Characteristics of qualitative changes of T-reg lymphocytes in chronic obstructive pulmonary disease and bronchial asthma patients/M. Tikhomirova, Z. Abramova//FEBS Open Bio. - 2018.-V.8.-S 1.-P.286-287 https://doi.org/10.1002/2211-5463.12453/ P.09-247-Mon.
6. Gordon, R.E. Statins synergize with Hedgehog pathway inhibitors for treatment of medulloblastoma / R.E. Gordon, L. Zhang, S. Peri, Y-M. Kuo, F. Du, B.L. Egleston, J.M.Y. Ng, A.J. Andrews, I. Astsaturov, T. Curran, Z.J. Yang // Clinical Cancer Research. – 2018. –V.24. – P.1375-1388.
7. Abramov, S. The effect of the risk allele A of rs200395694 associated with SLE in Swedish patients on MEF2D gene regulation and alternative splicing / Abramov, S; Kozyrev, S; Farias, FH; Dahlqvist, J; Leonard, D; Wilbe, M; Alexsson, A; Pielberg, GR; Hansson-Hamlin, H; Goran, A; Tandre, K; Eloranta, ML; Ronnblom, LE; Lindblad-Toh, K // FEBS OPEN BIO. – 2018. - Vol.8, Is.. - P.146-146.
8. Boumber Y. Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer/ Boumber Y. // J Thorac Dis. 2018 Aug;10(8):4689-4693. doi: 10.21037/jtd.2018.07.120.
9. Boumber Y.  Comparison of circulating tumor cell (CTC) capture/identification methods and NanoString evaluation of gene expression in CTCs and cell-free circulating tumor mRNA (cctmRNA) in patients with metastatic lung cancer/ Y. Boumber, C. Aggarwal, C. Thrash-Bingham, P. Fittipaldi, P. Guseva, R. Vlasenkova, C.a Rao, J.Pei, Br. L. Egleston, H.Borghaei, M. Cristofanilli, R. Mehra, I. Serebriiskii and R. K. Alpaugh // Cancer Research. - Volume 78, Issue 13 Supplement, pp. 1584
10. Topchu Y. Non-small lung carcinoma cells exhibit signs of EMT in response to cisplatin treatment and after development of cisplatin resistance / Topchu Y., Mazitova A., Abramova Z., Gabbasov R.//Human Gene Therapy. - 2018. -V. 27. - A53–A54 (November 2018) DOI: 10.1089/hum.2018.29077.abstracts
11. Abramov S. THE ROLE OF AUTOPHAGY EXPRESSION IN T-LYMPHOCYTES OF PATIENTS WITH SEVERE ASTHMA / S Abramov, E.M. Biktagirova, M.V. Tikhomirova, Y.V. Skibo // Human Gene Therapy. – 2018. – Vol. 29, No. 12. – P.A45.
12. Biktagirova E.M. Effect of dexamethasone on autophagy induction in T-lymphocytes of patients with mild bronchial asthma / E.M. Biktagirova, S.A. Abramov, M.V. Tikhomirova, Y.V. Skibo // Human Gene Therapy. – 2018. – Vol. 29, No. 12. – P.A45.
13. Tikhomirova M. Characteristics of qualitative changes of T-reg lymphocytes in chronic obstructive pulmonary disease and bronchial asthma patient s/ M. Tikhomirova, Z. Abramova // FEBS Open Bio.-2018.-V.8.-S 1.-P.286-287
14. S.N. Abramov The risk allele A of rs200395694 associated with SLE in Swedish patients affects on MEF2D gene regulation and alternative splicing /S.N. Abramov, S.V. Kozyrev, F.H.G. Farias, J. Dahlqvist, D. Leonard, M. Wilbe, A. Alexsson, G.R. Pielberg, H. Hansson-Hamlin, G. Andersson, K. Tandre, M.-L. Eloranta4, L. Rönnblom, K. Lindblad-Toh // FEBS OPEN BIO. - 2018. - Vol.8, Is.. - P.146-146.
15. F.Farias A rare regulatory variant in the MEF2D gene affects gene regulation and splicing and is associated with a SLE sub-phenotype in Swedish cohorts / F.Farias, J. Dahlqvist, S. Kozyrev, D. Leonard, M. Wilbe, S. Abramov, A.Alexsson, G. Pielberg, H. Hansson-Hamlin, G. Andersson, K.Tandre, A. Bengtsson, C.Sjöwall, E.Svenungsson, I. Gunnarsson, S.Rantapää-Dahlqvist, A. Syvänen, J. Sandling, M. Eloranta, L. Rönnblom, and K.Lindblad-Toh // European Journal of Human Genetics. - 2018. - Vol., Is.


1. Gaponova A. Identification of evolutionary conserved DNA damage response genes that al­ter sensitivity to cisplatin // A. Gaponova, A. Deneka, T. Beck, H. Liu, G. Andrianov, A. Nikonova, E. Nicolas, M. Einarson, E. Golemis and I. Serebriiskii. Oncotarget. 2016 Nov 15. doi: 10.18632/oncotarget.13353
2. V. Korobeynikov, A. Deneka, E. Golemis. Mechanisms for nonmitotic activation of Aurora-A at cilia. Biochemical Society Transactions (Portland Press). – 2016. – 0. 1-13. DOI: 10.1042/BST20160142C
3. Small, H.Y. HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia / Small, H.Y. ,  Akehurst, C.,  Sharafetdinova, L.,  McBride, M.W.,  McClure, J.D.,  Robinson, S.W.,  Carty, D.M.,  Freeman, D.J.,  Delles, C. //  Physiological Genomics. -2017. - 49(3):193-200.

4. Deneka A.Y. Tumor-targeted SN38 inhibits growth of early stage non-small cell lung cancer (NSCLC) in a KRas/p53 transgenic mouse model / Deneka AY, Haber L, Kopp MC, Gaponova AV, Nikonova AS, Golemis EA // PLoS One. -  2017. doi: 10.1371/journal.pone.0176747

5. Kozlova O. The role of heat shock proteins in response to stress / O. Kozlova, J. Topchu, S. Abramov, M. Tikhomirova & Z. Abramova // European Journal of Clinical Investigation.-2017.-Vol. 47, Issue Supplement S1.-P.158 (P12.05)]

6. Skripova V. CRISPR/Cas9 technique for identification of genes regulating oxaliplatin resistance of pancreatic cancer cell line / V. Skripova, I. Serebriiskii, Z. Abramova, I. Astsaturov, R. Kiyamova. – BioNanoScience. – 2017. – V. 7(1). – P. 97-100. DOI: 10.1007/s12668-016-0272-3

7. Abramov S.N.Autophagy of T-lymphocytes in the pathogenesis of patients with severe asthma / S.N. Abramov, Y.V. Skibo, V.G. Evtugyn, S.A. Vodounon, Z.I. Abramova//  BioNanoScience. – 2017. – V. 7 (2). – P. 269-271.  DOI: 10.1007/s12668-016-0337-3 

8. Boland P.M. Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by Resection / Boland PM, Meyer JE, Berger AC, Cohen SJ, Neuman T, Cooper HS, Olszanski AJ, Davey M, Cheng JD, Lebenthal A, Burtness BA, Scott WJ, Astsaturov IA. - Am J Clin Oncol. -  2017. – V. 40 (4). – P. 393-398.  


1. Ramakodi M.P. Ancestral-derived effects on the mutational landscape of laryngeal cancer / M.P. Ramakodi, R.J. Kulathinal, Y. Chung, I. Serebriiskii, J.C. Liua, Camille C. Ragina // Genomics. – 2016. – V. 107, Issues 2-3. – P. 76–82. doi:10.1016/j.ygeno.2015.12.004

2. Vodounon C.A. Nuclease activity associated with secreting granules by lymphocytes in patients with bronchial asthma / C. A. Vodounon, Z. I. AbramovaY. V. Skibo, I. D. Reshetnikova, S. A. Akpona, H. Sina, L. Baba-Moussa // Biology and Medicine. – 2016. – V.8 (1). - doi:10.4172/0974-8369.1000264

3. Kudinov A. Musashi-2 (MSI2) supports TGF-β signaling and inhibits claudins topromote non-small cell lung cancer (NSCLC) metastasis / A. Kudinov, A. Deneka, A.S. Nikonova, I.G. Serebriiskii, T.N. Beck, Young-Ho Ahn, X. Liu, Dong-Hua Yang, K.Q. Cai, K.M. Yaghmour, K.A. Baker, B.L. Egleston, E. Nicolas, A. Chikwem, G. Andrianov, S. Singh, H. Borghaei, D.L. Gibbons, J.M. Kurie, E.A. Golemis, Y. Boumber // PNAS. – 2016. - V.113 (25). - P. 6955-6960. doi: 10.1073/pnas.1513616113.

4. Kozyreva V.K. Combination of Eribulin and Aurora A inhibitor MLN8237 prevents metastatic colonization and induces cytotoxic autophagy in breast cancer / V.K. Kozyreva, A. Kiseleva, R. J. Ice, B. C. Jones, Y. V. Loskutov, F. Matalkah, M. B. Smolkin, K. Marinak, R. H. Livengood, M. A. Salkeni, S. Wen, H.W. Hazard, G. P. Layne, C. M. Walsh, P. Cantrell, G. W. Kilby, S. Mahavadi, N. Shah, E. N. Pugacheva // Molecular Cancer Therapeutics. – 2016. – V.15 (8). -– P. 1809-1822. DOI: 10.1158/1535-7163.MCT-15-0688

5. Beglyarova N. Screening of conditionally reprogrammed patient-derived carcinoma cells identifies ERCC3-MYC interactions as a target in pancreatic cancer / N. Beglyarova, E. Banina, Y. Zhou, R. Mukhamadeeva, G. Andrianov, E. Bobrov, E. Lysenko, N. Skobeleva, L. Gabitova, D. Restifo, M. Pressman, I.G. Serebriiskii, J.P Hoffman, K. Paz, D. Behrens, V. Khazak, S.A Jablonski, L. M. Weiner, E. A. Golemis, I. Astsaturov // Clinical cancer research. – 2016. – V.22 (15). [Epub ahead of print]

6. Gaponova A. V. A novel HSP90 inhibitor-drug conjugate to SN38 is highly effective in small cell lung cancer (SCLC) / A. V. Gaponova, A. Nikonova, A. Y. Deneka, M.C. Kopp, A.E. Kudinov, N. Skobeleva, V. Khazak, L. Shin Ogawa, K.Q. Cai, K.E. Duncan, J.S. Duncan, B.L. Egleston, D.A. Proia, Y. Boumber, E. A. Golemis // Clinical Cancer Research. – 2016. – V.22 (15). DOI: 10.1158/1078-0432.CCR-15-3068 Published June 2016 [Epub ahead of print]

7. Beck T.N. Anti-Müllerian hormone signaling regulates epithelial plasticity and chemoresistance in lung cancer / T.N. Beck, V.A. Korobeynikov, A.E. Kudinov, R. Georgopoulos, N. R. Solanki, M. Andrews-Hoke, T.M. Kistner, D. Pépin, P.K. Donahoe, E. Nicolas, M.B. Einarson, Y. Zhou, Y. Boumber, D.A. Proia, I.G. Serebriiskii, E.A. Golemis // Cell Reports. – 2016. - V.16 (3). – P. 657-671. doi: 10.1016/j.celrep.2016.06.043. Epub 2016 Jul 7

8. Kurimchak A.M. Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer / A.M. Kurimchak, C. Shelton, K.E. Duncan, K. Johnson, J. Brown, S. O'Brien, R. Gabbasov, L. Fink, Y.S. Li, W. E. Childers, D. C. Connolly, J. Chernoff, J. R. Peterson, J. S. Duncan // Cell Reports. – 2016. – V.16. – P. 1273–1286. DOI:http://dx.doi.org/10.1016/j.celrep.2016.06.091

9. Zhang Y. Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation / Yong-Wei Zhang, Rochelle E. Nasto, Rency Varghese, Sandra A. Jablonski, Ilya G Serebriiskii, Rishi Surana, Ionut Bebu, Joseph Murra, Lu Jin, Michael Johnson, Rebecca Riggins, Habtom Ressom, Emmanuel Petricoin, Robert Clarke, Erica A. Golemis, and Louis M. Weiner // Oncogene. - 2016. – V.35 (13). – P. 1643–1656. doi: 10.1038/onc.2015.226. 

10. Shadrina A.S. Polymorphisms in the MTHFR and MTR genes and the risk of varicose veins in ethnical Russians / A.S.  Shadrina,  K.S. Sevost'ianova,  A.I. Shevela,  E.Y. Soldatsky,  E.I. Seliverstov,  M.Y. Demekhova,  O.A. Shonov,  E.A. Ilyukhin,  M.A. Smetanina,  E.N. Voronina,  I.V. Pikalov,  I.A. Zolotukhin,  M.L. Filipenko // Biomarkers. – 2016. -  V. 21. – P. 619-624. DOI: 10.3109/1354750X.2016.1171902

11. Beck T.N. EGFR and RB1 as dual biomarkers in HPV-negative head and neck cancer /  Beck T.N., Georgopoulos R., Shagisultanova E.I., Sarcu D., Handorf E.A., Dubyk C., Lango M.N., Ridge J.A., Astsaturov I.Serebriiskii I.G., Burtness B.A., Mehra R., Golemis E.A. // // Molecular Cancer Therapeutics. – 2016. – V.15(10). – P. 2486-2497. DOI: 10.1158/1535-7163.MCT-16-0243

12.  Gaponova A.V.  Identification of evolutionarily conserved DNA Damage Response (DDR) genes that al­ter sensitivity to cisplatin/ Gaponova AV, Serebriiskii IG, Andrianov G, Kiyamova RG, Golemis EA // Annals of Oncology 27: vi526–vi544, 2016, P.1557 doi:10.1093/annonc/mdw392.38

13. Biktagirova  E. M. Biochemical & immunological markers of autoimmune thyroiditis / Biktagirova, E.M.,  Sattarova, L.I.,  Vagapova, G.R.,  Skibo, Y.V.,  Chuhlovina, E.N.,  Kravtsova, O.A.,  Abramova, Z.I. // Biomeditsinskaya Khimiya. - Volume 62, Issue 4. - P. 458-465

14. Skripova V. CRISPR/Cas9 technique for identification of genes regulating oxaliplatin resistance of pancreatic cancer cell line / V. Skripova, I. Serebriiskii, Z. Abramova, I. Astsaturov, R. Kiyamova. – BioNanoScience. – 2016. DOI: 10.1007/s12668-016-0272-3

15. Abramov S.N., Skibo Y.V. Autophagy of T-lymphocytes in the pathogenesis of patients with severe asthma / Abramov S.N., Skibo Y.V., Evtugyn V.G., Vodounon S.A., Abramova  Z.I. – BioNanoScience. – 2016. DOI: 10.1007/s12668-016-0337-3


1. Gritsina G. Targeted blockade of JAK/STAT3 signaling inhibits ovarian carcinoma growth / G. Gritsina, F.Xiao, S.W. O'Brien, R.Gabbasov et.al. // Molecular cancer therapeutics. – 2015. – V. 14(4). – P. 1035-1047. doi: 10.1158/1535-7163.MCT-14-0800

2. Ramirez U.D. Compounds identified by virtual docking to a tetrameric EGFR extracellular domain can modulate Grb2 internalization / Ramirez, U.D., Nikonova, A.S., Liu, H., Pecherskaya, A., Lawrence, S.H., Serebriiskii, I.G., Zhou, Y., Robinson, M.K., Einarson, M.B., Golemis, E.A., Jaffe, E.K. – BMC Cancer. – 2015. – V. 15(1). - Article number 436. - DOI: 10.1186/s12885-015-1415-6

3. Beck T.N. Phospho-T356RB1 predicts survival in HPV-negative squamous cell carcinoma of the head and neck / Beck, T.N., Kaczmar, J., Handorf, E, Nikonova, A., Dubyk, C., Peri, S., Lango, M., Ridge, J.A., Serebriiskii, I.G., Burtness, B., Golemis, E.A., Mehra, R. // Oncotarget. – 2015. – V.6 (22). – P. 18863-18874. DOI: 10.18632/oncotarget.4321

4. Shadrina A. TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population // A.S. Shadrina , U.A. Boyarskikh, N.A. Oskina, T.V. Sinkina, A.F. Lazarev, V.D. Petrova, M.L. Filipenko // Tumour Biol. – 2015. – V.36 (2). – P. 841-847. doi: 10.1007/s13277-014-2688-0. Epub 2014 Oct 10.

5. Vodounon C.A. Role of the autoantibodies in the pathogenesis of patients with atopic bronchial asthma / C.A. Vodounon, Z.I. Abramova, C.B. Chabi, R.A. Kurbanov, D.I. Reshetnikova, Y.V. Skibo, A. Sezan, S.O. Kotchoni, S.A. Akpona, L. Baba-Moussa // Research Journal of Immunology. – 2015. – V.8, Issue 1. – P. 1-16. DOI: 10.3923/rji.2015.1.16

6. Zhang Y. Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation / Yong-Wei Zhang, Rochelle E. Nasto, Rency Varghese, Sandra A. Jablonski, Ilya G Serebriiskii, Rishi Surana, Ionut Bebu, Joseph Murra, Lu Jin, Michael Johnson, Rebecca Riggins, Habtom Ressom, Emmanuel Petricoin, Robert Clarke, Erica A. Golemis, and Louis M. Weiner // Oncogene. - 2015 Jul 13. doi: 10.1038/onc.2015.226. [Epub ahead of print]

7. Shagisultanova E. Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases / E. Shagisultanova, A.V. GaponovaR. Gabbasov, E. Nicolas, E.A. Golemis // Gene. – 2015. - V. 567 (1). - P. 1–11. doi:10.1016/j.gene.2015.04.086

8. Biktagirova E.M. Biochemical and immunological markers of autoimmune thyroiditis / E. M. Biktagirova, L. I. Sattarova, G. R. Vagapova, Y. V. Skibo, E. N. Chuhlovina, O. A. Kravtsova, and Z. I. Abramova // Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. – 2015. - Vol. 9, No. 2. – P. 151–158. DOI: 10.1134/S1990750815020031

9. Akehurst C. Differential expression of microRNA-206 and its target genes in preeclampsia / Akehurst C, Small HY, Sharafetdinova L, Forrest R, Beattie W, Brown CE, Robinson SW, McClure JD, Work LM, Carty DM, McBride MW, Freeman DJ, Delles C. // J Hypertens. 2015 Aug 11. [Epub ahead of print]. October 2015 – V. 33, Issue 10 – P. 2068–2074. doi: 10.1097/HJH.0000000000000656

10. Gabitova L. Endogenous sterol metabolites regulate growth of EGFR/KRAS-dependent tumors via LXR / Gabitova L, Restifo D, Gorin A, Manocha K, Handorf E, Yang DH, Cai KQ, Klein-Szanto AJ, Cunningham D, Kratz LE, Herman GE, Golemis EA, Astsaturov I. // Cell Reports. – 2015. – V. 12, Issue 11. - P. 1927–1938.

11. Arora S. Genetic variants that predispose to DNA double-strand breaks in lymphocytes from a subset of patients with familial colorectal carcinomas / Arora S, Yan H, Cho I, Fan HY, Luo B, Gai X, Bodian DL, Vockley JG, Zhou Y, Handorf E, Egleston BL, Andrake M, Nicolas E, Serebriiskii I, Yen TJ, Hall MJ, Golemis EA, Enders GH. // Gastroenterology. - 2015. – V. 149(7). – P. 1872-1883.e9. doi: 10.1053/j.gastro.2015.08.052. [Epub ahead of print]

12. Nicolas E. Systematic evaluation of underlying defects in DNA repair as an approach to case-only assessment of familial prostate cancer / Nicolas E., Arora S., Zhou Y., Serebriiskii I.G., Andrake M.D., Handorf E.D., Bodian D.L., Vockley J.G., Dunbrack R.L., Ross E.A., Egleston B.L., Hall M.J., Golemis E.A., Giri V.N., Daly M.B. / Oncotarget. – V. 6 (37). – P. 39614-39633. doi: 10.18632/oncotarget.5554.

13. Garifulin O.M. Application of SEREX-analysis to four cases of human primary colon cancer / O.M. Garifulin, V.O. Kykot, N.Y. Gridina, R.G. Kiyamova, I.T. Gout, V.V. Filonenko // Exp Oncol. – 2015. – V. 37(3). - P. 1–8.

14. Deneka A. Embryonal Fyn-associated substrate (EFS) and CASS4: The lesser-known CAS protein family members / Deneka A., Korobeynikov V., Golemis E.A. // Gene. – 2015. – V. 570 (1). – P. 25-35. doi: 10.1016/j.gene.2015.06.062.

15. Nikonova A. Opposing Effects of Inhibitors of Aurora-A and EGFR in Autosomal-Dominant Polycystic Kidney Disease / Nikonova A., Deneka A., Eckman L., Kopp M.C., Hensley H.H., Egleston B.L., Golemis E.A. // Frontiers in oncology. – 2015. – V. 5. – P. 228. DOI:10.3389/fonc.2015.00228

16. Sokolova E.A. Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) association in Russian Diabetes Mellitus 2 type cohort and meta-analysis / E.A. Sokolova, I.A. Bondar, O.Y. Shabelnikova, O.V. Pyankova, M.L. Filipenko // PLoS One. – 2015. – DOI: 10.1371/journal.pone.0124662

17. Ermolenko N.A. Massive parallel sequencing for diagnostic genetic testing of BRCA genes - A single center experience / N.A. Ermolenko, U.A. Boyarskikh, A.A. Kechin, A.M. Mazitova, E.A. Khrapov, V.D. Petrova, A.F. Lazarev, N.E. Kushlinskii, M.L. Filipenko // Asian Pac J Cancer Prev. – V. 16 (17). – P. 7935-7941.


1. Perkins J. Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study // J. Perkins; P. Boland, S. J. Cohen, A. J. Olszanski, Y. Zhou, P. Engstrom, I. Astsaturov // Journal of the National Comprehensive Cancer Network. – 2014. - V. 12, Issue 6. – Р. 847-852.

2. Gabitova L. Molecular Pathways: Sterols and Receptor Signaling in Cancer // L. Gabitova, A. Gorin, I. Astsaturov // Clin Cancer Res. - 2014. - V.20. - Р. 28-34. doi: 10.1158/1078-0432.CCR-13-0122

3. Vodounon C. A. Influence of the programmed cell death of lymphocytes on the immunity of patients with atopic bronchial asthma / C. A. Vodounon, C. B. Chabi, Y. V. Skibo, V. Ezin, N. Aikou, S. O. Kotchoni, S. A. Akpona, L. Baba-Moussa, Z. I. Abramova //Allergy Asthma and Clinical Immunology. – 2014. – V. 10(14). doi:10.1186/1710-1492-10-14

4. Purdy A K. The AP-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor (KIR) in human NK cells / A. K. Purdy, D. A. Alvarez-Arias, J. Oshinsky, A. M. James, I. Serebriiskii, and K. S. Campbell // Journal of Immunology. - 2014. - V.193, Issue 9. - P. 4675-4683.

5. Abd El-Rahman A.A. Cytotoxicity of Trichoderma spp. cultural filtrate against human cervical and breast cancer cell lines / Atef Abd El-Mohsen Abd El-Rahman,S. M. El- Shafei, E. V. Ivanova, A. N. Fattakhova, A. V. Pankova, M. A. El-Shafei, El-Morsi Abu El-Fotouh El-Morsi, F. K. Alimova// Asian Pacific Journal of cancer prevention. - 2014. - V.15. Issue 17. – P. 7229-7234. DOI:http://dx.doi.org/10.7314/APJCP.2014.15.17.7229

6. Фатхуллина А.Р. Влияние дексаметазона на экспрессию генов bcl-2 и mTOR в Т-лимфоцитах здоровых доноров / А.Р. Фатхуллина, С.Н. АбрамовЮ.В. СкибоЗ.И. Абрамова // Цитология. - 2014. - Т.56, №6. - C. 459-461.

7. Shadrina, A. S. Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case–control study / A. S. Shadrina, N. A. Ermolenko, U. A. Boyarskikh, T. V. Sinkina, A. F. Lazarev, V. D. Petrova, M. L. Filipenko. // Clinical and Experimental Medicine. - 2014. – P. 1-8. DOI 10.1007/s10238-014-0329-y

8. Рагинов И.С. Влияние Р2-рецепторов на цитотоксическое действие цисплатина в культуре клеток рака шейки матки / Рагинов И.С., Мухамедьярова Г.К., Панов А.В. // Гены и клетки. - 2014. - Т.9. - № 3. – С. 240-241.